Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2018 · 10-Q
Revenue$439.18M$439.18M+8.2% vs Q1 2017 Net Income$45.00M$45.00M+50.8% vs Q1 2017 EPS Diluted$2.66$2.66+49.4% vs Q1 2017 Operating Income$56,397,000+36.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$52,545,000−12.1% Margins · derivedOperating margin12.8%+2.6 pt vs Q1 2017
Net margin10.2%+2.9 pt vs Q1 2017
ended Mar 31, 2018 · filed Apr 27, 2018 · 27 d after period end